Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach
Non-alcoholic fatty liver disease (NAFLD) is becoming the leading cause of liver morbidity worldwide and, as such, represents the pathogenic background for the increasing incidence of hepatocellular carcinoma (HCC). The annual incidence of NAFLD-related HCC is expected to increase by 45–130% by 2030...
Saved in:
Main Authors: | Ivica Grgurevic, Tonci Bozin, Mislav Mikus, Michal Kukla, James O’Beirne |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/1350f22a4dbf4015b811dec5b0c2b829 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
by: Satoru Hagiwara, et al.
Published: (2021) -
Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies
by: Aleksandr E. Nosov, et al.
Published: (2021) -
Non-Alcoholic Fatty Liver Disease and Hypothyroidism: Review of Clinical and Experimental Studies
by: Tetiana Ranhulova
Published: (2021) -
Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome
by: Aleksandr I. Pavlov, et al.
Published: (2021) -
A Non-Invasive Prediction Model for Non-Alcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Based on the Population of Northern Urumqi, China
by: Xue M, et al.
Published: (2021)